Litigation Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. LUPIN ATLANTIS HOLDINGS SA (D.N.J. 2018)
✉ Email this page to a colleague
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. LUPIN ATLANTIS HOLDINGS SA (D.N.J. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-08-10 |
| Court | District Court, D. New Jersey | Date Terminated | 2021-10-28 |
| Cause | 15:1126 Patent Infringement | Assigned To | Brian R. Martinotti |
| Jury Demand | Defendant | Referred To | Tonianne J. Bongiovanni |
| Patents | 7,694,676; 8,022,082; 9,010,323; RE38,912 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. LUPIN ATLANTIS HOLDINGS SA
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. LUPIN ATLANTIS HOLDINGS SA (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-10-28 | 217 | Order of Dismissal | ii) the term “Licensed Patent” shall mean United States Patent Number 7,694,676; and (iii) the term “Affiliate…assigns, is enjoined from infringing the Licensed Patent, on its own part or through any Affiliate, by …2018 28 October 2021 2:18-cv-12663 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
| 2019-10-30 | 70 | of Lupin's Counterclaims Concerning U.S. Patent Nos. 8,022,082, 9,010,323, and RE38,912. (Attachments: …2018 28 October 2021 2:18-cv-12663 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
